| Part Of Food & Drug Administration Oversight
Report Video IssueFDA Transparency and Oversight, Open Data Panel
2018-01-16T09:46:27-05:00https://ximage.c-spanvideo.org/eyJidWNrZXQiOiJwaWN0dXJlcy5jLXNwYW52aWRlby5vcmciLCJrZXkiOiJGaWxlc1wvNDYzXC8yMDE4MDExNjEwMjgyMDAwM19oZC5qcGciLCJlZGl0cyI6eyJyZXNpemUiOnsiZml0IjoiY292ZXIiLCJoZWlnaHQiOjUwNn19fQ==Doctors and medical researchers talked about transparency at the Food and Drug Administration, and how the release of data can advance the development of medical products and improve health.
Doctors and medical researchers talked about transparency at the Food and Drug Administration, and how the release of data can advance the development of medical products and improve health.
People in this video
-
Joshua M. Sharfstein M.D. Associate Dean Johns Hopkins University Bloomberg School of Public Health->Public Health Practice and Training -
Hosting Organization
More Videos From
Food & Drug Administration Oversight
- FDA Transparency and Oversight, Scott Gottlieb Keynote Speech
- FDA Transparency and Oversight, Open Data Panel
- FDA Transparency and Oversight, Investor Panel
- FDA Transparency and Oversight, Panel on Correcting Misinformation
Purchase a Download
FDA Transparency and Oversight, Open Data Panel
-
MP3 audio - Standard
- Price:
- $0.99
Related Video
-
FDA Transparency and Oversight, Investor Panel
A forum on transparency at the Food and Drug Administration featured a discussion on how transparency can affect investo…
-
FDA Transparency and Oversight, Panel on Correcting Misinformation
Physicians and medical researchers talked about ways for the Food and Drug Administration to correct misinformation in t…
-
Food Policy Conference, Day 2, Part 2
The Consumer Federation of America held its annual National Food Policy Conference in Washington, DC. In this portion, c…
-
Prescription Drugs
Members of Congress and industry experts talked about prescription drug access and costs. FDA Commissioner Scott Gottlie…